JONUŠAITĖ, I.; GIEDRAITIENĖ, N.; KAUBRYS, G.; KIZLAITIENĖ, R. The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab. Neurologijos seminarai, [S. l.], v. 27, n. 3 (97), p. 127–135, 2024. DOI: 10.29014/NS.2023.27.97.1. Disponível em: https://journals.vu.lt./neurologijos_seminarai/article/view/34911. Acesso em: 27 apr. 2025.